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Abstract
Purpose: Whole-heart dose metrics are not as strongly linked to late cardiac morbidities as radiation doses to individual cardiac
substructures. Our aim was to characterize the excursion and dosimetric variation throughout respiration of sensitive cardiac
substructures for future robust safety margin design.
Methods and Materials: Eleven patients with cancer treatments in the thorax underwent 4-phase noncontrast 4-dimensional
computed tomography (4DCT) with T2-weighted magnetic resonance imaging in end-exhale. The end-exhale phase of the 4DCT was
rigidly registered with the magnetic resonance imaging and reﬁned with an assisted alignment surrounding the heart from which 13
substructures (chambers, great vessels, coronary arteries, etc) were contoured by a radiation oncologist on the 4DCT. Contours were
deformed to the other respiratory phases via an intensity-based deformable registration for radiation oncologist veriﬁcation.
Measurements of centroid and volume were evaluated between phases. Mean and maximum dose to substructures were evaluated
across respiratory phases for the breast (n = 8) and thoracic cancer (n = 3) cohorts.
Results: Paired t tests revealed reasonable maintenance of geometric and anatomic properties (P < .05 for 4/39 volume comparisons).
Maximum displacements >5 mm were found for 24.8%, 8.5%, and 64.5% of the cases in the left-right, anterior-posterior, and superiorinferior axes, respectively. Vector displacements were largest for the inferior vena cava and the right coronary artery, with
displacements up to 17.9 mm. In breast, the left anterior descending artery Dmean varied 3.03 § 1.75 Gy (range, 0.53-5.18 Gy)
throughout respiration whereas lung showed patient-speciﬁc results. Across all patients, whole heart metrics were insensitive to
breathing phase (mean and maximum dose variations <0.5 Gy).
Conclusions: This study characterized the intrafraction displacement of the cardiac substructures through the respiratory cycle and highlighted
their increased dosimetric sensitivity to local dose changes not captured by whole heart metrics. Results suggest value of cardiac substructure
margin generation to enable more robust cardiac sparing and to reduce the effect of respiration on overall treatment plan quality.
© 2021 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Introduction
Radiation dose to the heart from thoracic cancer radiation therapy (RT) may increase risks of ischemic heart
disease, cardiomyopathy, and artery atherosclerosis.1,2
Currently, only whole heart dose/volume estimates are
considered for RT planning in clinical practice.3 Recent
studies have shown that dose to individual substructures
may be better indicators of future cardiac events than
whole heart dose metrics.4 A present challenge of improving cardiac substructure sparing during the treatment
planning process is that they are difﬁcult to discern on
standard computed tomography (CT) simulation scans.
High resolution CT coronary angiography drastically
improves the visualization of the coronary arteries,5
although CT coronary angiography is most commonly
used to evaluate vascular disease6 and also requires the
use of contrast. Magnetic resonance imaging (MRI) provides soft tissue discrimination and allows for substructure visualization. However, cardiac MRIs and MRIs
acquired of the thoracic region are not standard of care
for radiation treatment planning due to high costs, accessibility limitations, and technical challenges introduced by
susceptibility artifacts caused by air-tissue interfaces.7
Aside from localizing cardiac substructures for initial
treatment planning, assessing dose and developing cardiac
spared plans may be further complicated by substructure
intrafraction motion. Guzhva et al8 evaluated 10-phase 4dimensional (4D) CTs to analyze the combined intrafractional cardiac and respiratory motion of 12 cardiac substructures for 20 patients undergoing RT for thoracic
cancers. Substructure segmentations were completed on
the 50% phase (end-exhalation [EE]) and then deformably
propagated to the remaining phases.8 They found that the
largest centroid displacements from intrafractional motion
were in the superior-inferior (S-I) axis and that the cardiac
chambers yielded the smallest displacements overall (largest displacements in the coronary vessels).8
Several studies have reported on the dosimetric effect
of intrafractional motion on the heart during thoracic
cancer RT. A study by George et al9 studied the effects of
intrafraction motion for breast cancer treatments using
intensity modulated radiation therapy under shallow, normal, and deep breathing conditions and found that heart
dose/volumetric endpoints increased with increased respiratory excursion. Similarly, Yue et al10 evaluated the effect
of intrafraction motion arising from respiration on dosevolume histogram metrics for left breast cancer treatments using 10-phase 4DCT, revealing that maximum
heart doses varied up to 6 Gy under normal respiratory
conditions. El-Sherif et al11 evaluated 10-phase 4DCTs for
intrafraction motion evaluation of left-sided breast cancer
treatments and included the whole heart, left ventricle
(LV), and left anterior descending artery (LADA). This
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work revealed that although the 95% conﬁdence interval
of the 4D dose was §0.5 Gy for the whole heart, it varied
§8.7 Gy for the LADA, thus underscoring the importance
of evaluating dose to individual cardiac substructures and
the potential sensitivity to the effects of respiration.
This work sought to (1) quantify the excursion of 13
cardiac substructures during respiration by applying segmentation pipelines to 4DCT data coupled with deformable image registration (DIR) and (2) examine areas of
potential dosimetric effect. Our study builds upon the current literature by providing population results and including additional substructures, such as the left main coronary
artery (LMCA) and the great vessels (ie, superior vena cava
[SVC], ascending aorta [AA], and pulmonary artery [PA]).
Additionally, the current study provides volume and dose
statistics across respiratory phases. When combined with
interfraction uncertainties and cardiac motion assessments,
a robust safety margin for cardiac substructures can be
deﬁned to ensure adequate cardiac sparing.

Methods and Materials
Patient cohort and imaging
Eleven patients with cancer were retrospectively
reviewed in an institutional review board approved study
conducted at the Henry Ford Cancer Institute. Detailed
demographic and treatment-related information for each
patient included in our study is outlined in Table 1. These
patients either underwent 4-phase (n = 8, patients with
breast cancer) or 10-phase (n = 3, patients with lesions in
the thoracic region) noncontrast 4DCTs. All initial dose
calculations and treatment planning were conducted on
the average CT per our standard clinical workﬂow. All
patients were imaged with a respiratory correlated 4DCT
and cardiac gated T2-weighted MR in EE. Reconstructed
data were exported from the clinical scanners and deidentiﬁed for analysis. The EE phase of the 4DCT was rigidly registered with the EE MRI and the registration was reﬁned
with an assisted alignment surrounding the heart using
MIM (version 6.9.1; MIM Software Inc, Cleveland, OH).

Autosegmentation
Thirteen cardiac substructures including the heart, LV/
right ventricle, left atrium/right atrium (RA), pulmonary
vein, PA, AA, SVC/inferior vena cava (IVC), LADA,
LMCA, and right coronary artery (RCA) were automatically segmented using multiatlas12 (n = 8) and deep learning techniques13 (n = 3) that used hybrid MRI/CT
information on the EE phase of the 4DCTs. These EE
delineations were veriﬁed and, if needed, corrected by a
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Table 1 Description of each patient case outlining gender, age, tumor histology, staging, tumor location, dose in Gy per
fx, and treatment technique
Patient

Sex

Age

Histology

Stage

Location

Dose (Gy/fx)

Technique

1

F

46

Invasive ductal carcinoma

IIIA

Breast

61.2/34

3D

2

F

64

Invasive ductal carcinoma

IA

Breast

52.72/21

3D

3

F

68

Invasive ductal carcinoma

IA

Breast

50.72/21

3D

4

F

59

Invasive lobular carcinoma

IIIC

Breast

50/25

3D

5

F

67

Invasive ductal carcinoma

IIA

Breast

61.2/34

3D

6

F

70

Invasive ductal carcinoma

IA

Breast

52.72/21

3D

7

F

48

Invasive ductal carcinoma

II

Breast

61.2/34

3D

8

F

61

Intraductal carcinoma in situ

0

Breast

52.72/21

3D

9

M

89

Small cell lung cancer

IIIA

Thorax

60/20

IMRT

10

M

73

High-grade pleomorphic sarcoma

IIA

Thorax

50/5

SBRT

11

M

69

Adenocarcinoma

IA

Thorax

48/4

SBRT

Abbreviations: 3D = 3-dimensional conformal; F = female; fx = fraction; IMRT = intensity modulated radiation therapy; M = male;
SBRT = stereotactic body radiation therapy.

physician before propagating contours to the other
phases. All initial physician delineations and subsequent
corrections followed a consensus contouring guideline for
cardiac segmentation.14
Figure 1 best summarizes the methods used for characterization of cardiac substructure excursion due to respiration. Physician-veriﬁed contours on the EE of the 4DCT
were deformed to the other phases using a constrained,
intensity-based, free-form DIR based on Demons, which
minimizes the intensity differences between 2 single modality data sets.15 Demons algorithms are widely used for their
accuracy and computational efﬁciency.16,17 This same DIR
algorithm from MIM software has been implemented in
several other CT to CT DIR studies18-20 and has been
reported to have a »1-mm error from gold standard deformations.21 To conduct the DIR, a box-based assisted alignment around the heart was ﬁrst completed. The DIR
workﬂow creates a set of grid control points using a coarseto-ﬁne, multiresolution approach that has been shown to
allow for anatomic alignment even when large differences
are present due to respiration.18 Regularization was also
implemented to minimize folds and tears in the deformation ﬁeld.18 Once the DIR was used to propagate segmentations to each phase of the 4DCT, ﬁnal contour veriﬁcation
was conducted by a radiation oncologist. Final analysis was
conducted to deﬁne the location of each cardiac substructure at end-inhalation (0%), EE (50%), and 2 intermediate
breathing phases (25%-30%, 70%-75%).

analysis. Maximum excursions in each direction were calculated and reported as mean § standard deviation. Displacements >5 mm for each of the 3 cardinal axes were
evaluated based on guidance provided by the respiratory
motion management report produced by the American
Association of Physicist in Medicine Task Group report
76.22 Paired t tests were employed for statistical analysis
of each substructure to compare contour volumes across
phases. Any P value < 0.05 was considered a statistically
signiﬁcant difference. All statistical analysis was performed using SPSS version 25.0 (SPSS, Chicago, IL).

Dosimetric analysis
To quantify differences in dosimetric endpoints, clinically approved treatment plans were transferred to the
evaluated phases of the 4DCTs (ie, 0%, 25%-30%, 50%,
and 70%-75%). The mean (Dmean) and maximum doses
(Dmax) were tabulated for each substructure and the largest dosimetric changes over the respiratory phases were
quantiﬁed. As the patient cohort consisted of breast and
thoracic cancer cohorts, percent dose variation over the
respiratory cycle was quantiﬁed.

Results
Cardiac substructure displacement

Analysis for statistical and quantitative
comparisons
Measurements of centroid and volume at each respiratory phase were exported from MIM for subsequent

Centroid displacements for the left-right (L-R), anterior-posterior (A-P), S-I, and vector shifts for the patient
population are shown in Figure 2. The location of each
cardiac substructure at end-inhalation (0%), EE (50%),
and 2 intermediate phases (25%-30%, 70%-75%) were
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Methods for characterization of cardiac substructure excursion due to respiration.

Figure 1
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evaluated in this study. The maximum vector displacements ranged from 5 to 10 mm across most substructures,
with the largest displacements occurring for the IVC and
the RCA with displacements up to 17.9 mm. Of the 3 cardinal axes, intrafraction centroid displacements were the
largest in the S-I axis. Maximum displacements of
>5 mm were found for 24.8%, 8.5%, and 64.5% of the
cases in the L-R, A-P, and S-I axes, respectively. As shown
by the boxplots in Figure 2, 10/13 substructures had
median intrafraction S-I centroid displacements ≥5 mm.
Further, only the S-I axis had a 95th data percentile that
extended past 15 mm (ie, IVC). For 10/13 studied cardiac
structures, data for the ﬁrst 3 quartiles were <5 mm in the
L-R axis. With regard to outliers, 8/9 outliers in the L-R
axis can be attributed to a single patient. Over all substructures, the A-P axis exhibited the least excursion. As
shown in Figure 2, median excursions for 11/13 structures
were smallest in the A-P axis. Table 2 also summarizes the
L-R, A-P, and S-I maximal displacements for each cardiac
substructure over the patient population.
When considering regional location of particular substructures, Table 2 reveals that the great vessels (ie, the
AA, SVC, and PA) exhibited the least amount of excursion along each axis, which was also conﬁrmed by
Figure 2. Both the IVC and the RCA, which are located at
the inferior aspect of the heart, had maximal centroid displacements that were >15 mm. Data presented in Figure 2
and Table 2 also reveal that the IVC was the substructure
with the largest displacements in the S-I axis. For the
RCA, 9/11 patients had S-I displacements >5 mm
whereas the IVC had 8 patients exceed this threshold. The

Figure 2 Intrafraction centroid displacement comparison between all 13 structures for each direction: left-right, anteriorposterior, superior-inferior, and vector. Boxplots, thick line, and whiskers represent the interquartile range (IQR), median,
and 5th and 95th percentiles, respectively. Data points displayed as a small circle represent a value >1.5 times the IQR and
the star represents a value >3 times the IQR.
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Table 2 Maximum displacement of individual cardiac substructures over 11 patients throughout the respiratory cycle in
each cardinal axis (left-right (L-R), anterior-posterior (A-P), and superior-inferior (S-I)) and vector displacements. Substructure abbreviations deﬁned in the text.
Substructure

L-R (mm)

A-P (mm)

S-I (mm)

Vector (mm)

Heart (n=9)

2.5 ± 2.7

1.5 ± 1.4

5.9 ± 2.5

6.6 ± 3.1

LV

3.1 ± 2.6

2.4 ± 1.8

6.3 ± 2.8

7.6 ± 3.4

LA

3.4 ± 2.0

1.9 ± 1.3

6.0 ± 2.2

7.0 ± 2.7

RV

3.9 ± 3.1

2.1 ± 1.4

6.1 ± 3.0

7.7 ± 3.6

RA

3.7 ± 2.5

2.1 ± 1.7

6.2 ± 2.6

7.5 ± 3.1

PA

2.9 ± 2.2

1.6 ± 1.1

4.9 ± 2.0

6.0 ± 2.5

AA

3.1 ± 2.5

1.4 ± 0.6

4.0 ± 1.7

5.4 ± 2.4

SVC

2.8 ± 2.6

1.4 ± 0.9

5.0 ± 2.3

5.7 ± 2.8

PV

3.9 ± 2.6

2.0 ± 1.2

5.2 ± 1.6

6.5 ± 2.5

IVC

3.2 ± 2.7

3.8 ± 2.5

8.5 ± 3.3

9.8 ± 3.4

RCA

5.3 ± 4.1

2.6 ± 1.2

7.8 ± 3.7

9.8 ± 4.1

LADA

3.0 ± 1.5

4.1 ± 1.3

7.1 ± 2.6

8.7 ± 2.5

LMCA

5.0 ± 3.5

2.7 ± 2.0

5.8 ± 2.4

8.2 ± 3.1

Individual Cardiac Substructure Excursion in Respiration

RCA and IVC each had the largest maximum vector displacements of >9 mm, as summarized in Table 2.
4DCT excursion analysis revealed that 52.5% and
31.9% of the maximum excursions over the respiratory
cycle occurred between the 0 and 50% and the 0 and 70%
(or 75%) trajectories, respectively. Maximum excursions
only occurred between the 0 and 30% (or 25%) phases
6.4% (9/141 instances) of the time.
Figure 3 shows substructure excursion between the 0%
(bottom row) and the 50% phase (top row) for 2 representative patients in both the axial and sagittal axes. Patient 1
(Fig 3, left) exhibited minimal substructure centroid displacement over the respiratory cycle. Patient 1 had
smaller than average vector displacements for 11/13 cardiac structures (LMCA had the largest vector excursion
for this patient of 11.8 mm). Even though the largest displacements were observed in the S-I axis across the population, patient 9 presented as an outlier that underwent
the largest L-R displacement across the cohort, with L-R
intrafraction displacements for 12/13 substructures
exceeding the Task Group (TG)-76 motion management
recommendation of 5 mm and an LADA displacement of
up to 13.5 mm and in the S-I axis centroid displacements
for all substructures >5.0 mm and up to 8.7 mm.

Volume and statistical analysis
The paired t tests revealed that out of 39 volume comparisons per patient (13 substructures, 4 phases), there
were only 4 instances with statistically signiﬁcant differences (P < .05) for the volume comparisons, suggesting

reasonable maintenance of geometric and anatomic properties. The average volume of the whole heart across all
patients at the 50% phase was 718.6 § 133.4 cc. On average, the percent difference in volume for the whole heart
between the 0% and 50% phases was 1.2 § 0.5%. The cardiac substructures with the largest variabilities in volume
between EE and end-inhale (EI) had average volumes >70
cc (PA and chambers), as shown in Appendix E1. The RA
had the largest volume differences between EE and EI of
7.8 § 6.5% (range, 0.9%-20.2%).

Dosimetric analysis
Over the 8 studied patients with breast cancer, the
LADA Dmean varied 3.03 § 1.75 Gy (range, 0.53-5.18 Gy)
whereas the whole heart Dmean changed 0.18 § 0.09 Gy
(range, 0.06-0.37 Gy) during respiration. Boxplots shown
in Figure 4 best summarize the mean doses to each individual substructure between end-inhalation (0% 4DCT
phase) and EE (50% 4DCT phase) for the left breast cancer cohort, highlighting that the most dominant differences were observed for the LADA.
The dose-volume histograms shown in Figure 5
across the 3 patients with lung cancer highlight
patient-speciﬁc results. Of the 3 patients with thoracic
cancer studied, patient 9 experienced the largest
changes in dose across respiratory phases (average
change in Dmax of 3.2 § 2.9 Gy [range, 0.46 PA-9.05
Gy RA] and Dmean was 2.2 § 1.8 Gy across cardiac
substructures). For the other 2 patients with thoracic
cancer treated with stereotactic body radiation therapy,
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Figure 3 Two representative patients showing substructure excursion between 0% (bottom row) and 50% phase (top
row) images with the contours from each phase shown on both image sets for the axial and the sagittal axes. Left: patient 1
selected for minimal displacement over respiration. Right: patient 9 chosen for largest left-right (L-R) displacement across
patients. Cardiac substructure abbreviations are deﬁned in the text.

no cardiac substructure had Dmean differences >1.4 Gy
(Dmax differences up to 5.6 Gy).
To show this in additional detail, Appendix E1 shows 2
representative patients with breast cancer with the heart,
ventricles, and LADA displayed over respiratory phases.
Both patient 2 and patient 6 were treated to 42.72 Gy in 16
fractions for a stage 1A malignant neoplasm of the left
breast. For these patients, the LADA (Appendix E1, green)
had a Dmean that varied >3.5 Gy over the respiratory cycle.

Discussion
By leveraging multiphase 4DCT data, this work sought to
quantify the intrafractional displacements of sensitive
cardiac substructures and summarize the dosimetric effect
throughout the respiratory cycle. Although other studies
have focused on intrafraction displacement of the whole
heart, our work further quantiﬁed displacement for additional cardiac substructures. Our methodology of using
4DCT and DIR was similar to a study by Guzhva et al,8
where contours were propagated from the 50% phase to
the other phases and then manually revised. They found
that vector intrafractional displacement of the cardiac
substructures ranged from 7 to 15 mm and was dominant
in the S-I axis.8 Our work agrees with these ﬁndings in
that substructure excursion from respiration was predominant in the S-I axis, and maximal vector displacements
ranged from 5 to 10 mm. Our study built on the work
conducted by Guzhva et al8 by considering the LMCA
and the LADA as separate cardiac substructures and
through the consideration of the great vessels (ie, SVC,
PA, and AA). This work also characterizes the dosimetric

effect at different phases in respiration for both breast and
thoracic cancer cases. However, both studies were limited,
as neither accounted for interobserver contouring variability and interfraction uncertainties.
This work found that substructures toward the superior
extent of the heart, the great vessels (ie, AA, SVC, and PA),
had the smallest displacements in each axis, whereas substructures at the inferior extent of the heart, the RCA and
the IVC, had the largest displacements. Limited cardiac
substructure excursion data are available for direct comparison; however, it has been reported that tumor excursion in
inferior lung lobes displaces the most over the respiratory
cycle.23,24 In the present study, the largest substructure centroid displacements occurred for the IVC, which is located
at the inferior aspect of the heart and passes through the
diaphragm at the vena caval foramen.25
Moreover, the dosimetric analysis conducted to evaluate
the effect of breathing phase on substructure dose revealed
that although changes in Dmean and Dmax for the heart
were less sensitive to respiration (<0.5 Gy), large dose differences for individual substructures were observed.
Figure 4 highlights the varied sensitivity of the mean cardiac substructure doses with respiration for the breast cancer cohort with the LADA Dmean varying »3 Gy during
respiration across the population. Figure 5 demonstrates
the effect of breathing phase on substructure dose for 3
patients with lung cancer. Patient 9 shows mean dose differences of >3 Gy with respiration for the AA, LMCA, pulmonary vein, and SVC with effect of respiration >8 Gy for
the maximum doses to the AA and RA. In a recent retrospective analysis of >700 patients with locally advanced
non-small lung cancer, after controlling for baseline risk
factors, radiation dose to several cardiac substructures,
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Figure 4 Mean doses to individual substructures (abbreviations deﬁned in the text) for the patient with breast cancer

cohort highlighting the dosimetric variation observed between end-inhalation (0% 4-dimensional computed tomography
[4DCT] phase) and end-exhalation (50% 4DCT phase).

including mean total coronary dose ≥7 Gy and mean
LMCA dose ≥27 Gy, had signiﬁcant associations with the
risk of major adverse cardiac events.26 This study also
revealed that in patients without congestive heart disease,

the LADA volume of dose receiving >15 Gy being ≥10%
was an independent estimator of the probability of major
adverse cardiac events and all-cause mortality. Higher
doses at the base of the heart, near the great vessels (AA,

Figure 5 Dose-volume histograms for patients 9, 10, and 11 with lesions in the thoracic region showing the dosimetric
variation across respiratory phases for the great vessels (top), the cardiac chambers (middle), and the coronary arteries
(bottom). Substructure color gradient transitions from dark to light as the respiratory phases pass from the 0% to the 70%
phase, respectively. Cardiac substructure abbreviations are deﬁned in the text. Patient 9 underwent intensity modulated
radiation therapy (IMRT) to 60 Gy while patients 10 and 11 received stereotactic body radiation therapy (SBRT) to 50
and 48 Gy, respectively. Note scales adjusted per graph to elucidate changes.
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SVC, and PA) have been shown to be associated with worse
patient survival,27 underscoring the importance of establishing accurate substructure safety margins for effective
cardiac sparing.
The boxplots shown in Figure 4 for the breast cancer
cases highlight that the most dominant differences were
observed for the LADA. Notably, doses to the LADA have
been linked to increased risk of radiation-induced cardiac
morbidity28 and myocardial infarctions.29 Recent work by
Nicolas et al30 evaluated cardiac-gated and planning CT
scans for 45 patients with left breast cancer and found
that LADA movement depended on the location and suggested a safety delineation margin of 10 mm. Other dosimetric endpoints varied based on tumor location,
underscoring the importance of patient-speciﬁc assessments and robust margin design. Recent work showed the
beneﬁts of using cardiac substructure-spared planning in
MR-guided RT for improved plan optimization across
several thoracic disease sites.31 Further work in gastroesophageal junction cancer highlighted the potential beneﬁts of incorporated MRI-guided RT on an MR-linac for
cardiac substructure sparing compared with conventional
CT-based volumetric modulated arc therapy planning.32
One limitation of this work is that only free breathing
conditions were evaluated using 4DCT. Deep inspiration
breath-hold may be employed to reduce dose to the heart
and subsequent cardiotoxicity risk,33 although evaluation
of deep inspiration breath-hold was beyond the scope of
this work. The limitation of uncertainties associated with
the DIR process (as outlined by American Association of
Physicist in Medicine TG 13234) was mitigated as segmentations at each phase of respiration were manually veriﬁed
and corrected. Another limitation is that isolating cardiac
excursion was not possible with respiratory-correlated
4DCTs, and thus, the excursions presented in this work
represented a contribution from combined respiratory
and cardiac motion effects. However, it was reported by
Tan et al35 that the LV and coronary arteries are the most
mobile substructures through the cardiac cycle, displacing
between 3 to 8 mm between end-diastolic and end-systolic phases. Thus, cardiac motion may be managed
through incorporation in future planning organ-at-risk
volume design. This work may also be limited in that only
4 phases of the 4DCT were used instead of 10, although
characterizing excursion and dosimetric effect for cardiac
substructures as well as determining the speciﬁc phases
where maximum centroid displacement occurred are
additional contributions to the literature.
This work included both patients with breast and thoracic cancer, which may have contributed to differing
dominant axes of motion from cardiac and respiration
inﬂuences. Guzhva et al8 did ﬁnd that patients with Hodgkin lymphoma had a tendency to have larger displacements in the S-I axis than patients with lung cancer,
which could be due to the comorbidities accompanying
smoking or otherwise compromised lung function.
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Therefore, inconsistencies in patient anatomy could also
cause uncertainty in determining the dominant axes of
excursion and may be circumvented through expanding
the patient cohort or grouping by disease site. This was
also observed in patient 3 with abnormal anatomy secondary to scoliosis, which caused the heart and substructures to traverse in predominantly the L-R axes compared
with the rest of the cohort where S-I was dominant. Nevertheless, this work was done to validate the need for consideration of cardiac substructures through the
incorporation of a motion model. This would provide an
opportunity to decrease cardiotoxicity risk during RT.

Conclusion
This work characterized the intrafraction displacement
of the cardiac substructures through the respiratory cycle
and quantiﬁed the potential dosimetric consequences.
This work suggests value of cardiac substructure planning
organ at risk volume generation to enable more robust
cardiac sparing and to reduce the effect of respiration on
overall treatment plan quality.

Supplementary materials
Supplementary material associated with this article can
be found in the online version at doi:10.1016/j.adro.2021.
100876.
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